#Alzheimer’s_Drug_Discovery_Foundation
LightNews LightNews
newsen.bsky.social
FDA Approves Subcutaneous Starting Dose for Leqembi, Revolutionizing Alzheimer's Treatment Modalities#United_States#New_York#FDA_Approval#Leqembi#Alzheimer's_Drug_Discovery_Foundation
FDA Approves Subcutaneous Starting Dose for Leqembi, Revolutionizing Alzheimer's Treatment Modalities
The FDA's recent approval of a subcutaneous starting dose for Leqembi improves accessibility for Alzheimer's patients, paving the way for future combination therapies.
third-news.com
July 13, 2026 at 11:13 PM
newsen.bsky.social
ADDF and MJFF Join Forces in $5 Million Initiative for Alzheimer's and Parkinson's Research#United_States#New_York#Parkinson's_Research#Michael_J._Fox_Foundation#Alzheimer's_Drug_Discovery_Foundation
ADDF and MJFF Join Forces in $5 Million Initiative for Alzheimer's and Parkinson's Research
The Alzheimer's Drug Discovery Foundation and the Michael J. Fox Foundation have launched a $5 million partnership to tackle key complexities of Alzheimer's and Parkinson's diseases.
third-news.com
July 13, 2026 at 2:27 PM
newsen.bsky.social
Alzheimer's Drug Discovery Foundation Seeks New Chief Science Officer Following Dr. Fillit's Transition#USA#New_York#Precision_Medicine#Alzheimer's_Drug_Discovery_Foundation#Dr._Howard_Fillit
Alzheimer's Drug Discovery Foundation Seeks New Chief Science Officer Following Dr. Fillit's Transition
The Alzheimer's Drug Discovery Foundation is searching for a new Chief Science Officer as Dr. Howard Fillit transitions to an emeritus role, aiming to continue advancing Alzheimer's research.
third-news.com
June 18, 2026 at 1:55 PM
newsen.bsky.social
Dr. Jeff Cummings' 2026 Alzheimer's Drug Report: A New Wave of Innovative Treatments#USA#New_York#Alzheimer's_Disease#Alzheimer's_Drug_Discovery_Foundation#Dr._Jeff_Cummings
Dr. Jeff Cummings' 2026 Alzheimer's Drug Report: A New Wave of Innovative Treatments
Dr. Jeff Cummings unveils a pivotal report on the Alzheimer's drug pipeline, marking a significant shift towards biology-driven therapies for better treatment outcomes.
third-news.com
May 5, 2026 at 3:48 PM
newsen.bsky.social
ADDF Unveils Advanced Phase of $150 Million Initiative for Alzheimer's Diagnostics and Precision Medicine#United_States#New_York#Precision_Medicine#Diagnostics_Accelerator#Alzheimer's_Drug_Discovery_Foundation
ADDF Unveils Advanced Phase of $150 Million Initiative for Alzheimer's Diagnostics and Precision Medicine
The Alzheimer's Drug Discovery Foundation has launched the third phase of its $150 million initiative focusing on advanced diagnostics for Alzheimer's disease, aiming for precision medicine.
third-news.com
March 17, 2026 at 2:00 PM
newsen.bsky.social
Leading the Charge in Alzheimer's Research: Isobel Coleman Appointed CEO of ADDF#United_States#New_York#Alzheimer's_Drug_Discovery_Foundation#Alzheimer's_Research#Isobel_Coleman
Leading the Charge in Alzheimer's Research: Isobel Coleman Appointed CEO of ADDF
Isobel Coleman has been appointed as the new CEO of the Alzheimer's Drug Discovery Foundation, set to lead transformative advancements in Alzheimer's research and drug development.
third-news.com
March 11, 2026 at 2:34 PM
newsen.bsky.social
ADDF Enhances Leadership for a New Era in Alzheimer's Research with Key Appointments#United_States#New_York#Alzheimer's_Drug_Discovery_Foundation#Gavin_Cook#David_Dolby
ADDF Enhances Leadership for a New Era in Alzheimer's Research with Key Appointments
The Alzheimer's Drug Discovery Foundation welcomes new leaders, including Gavin Cook and David Dolby to its Board and appoints Jane McIntosh as Interim CEO to enhance Alzheimer's research.
third-news.com
December 16, 2025 at 3:07 PM
newsen.bsky.social
Alzheimer's Drug Discovery Foundation Launches New Campaign Focused on Scientific Innovation#USA#Palm_Beach#Alzheimer's_Drug_Discovery_Foundation#Alzheimer's_Research#Milestones_in_Motion
Alzheimer's Drug Discovery Foundation Launches New Campaign Focused on Scientific Innovation
The Alzheimer's Drug Discovery Foundation introduces Milestones in Motion and the fifth symposium season, advancing Alzheimer's research and support.
third-news.com
November 19, 2025 at 4:10 PM
newsen.bsky.social
ADDF's Diagnostics Accelerator Launches SpeechDx Dataset and Teams Up with Callyope for Alzheimer's Research#United_States#New_York#Alzheimer's_Drug_Discovery_Foundation#Callyope#SpeechDx
ADDF's Diagnostics Accelerator Launches SpeechDx Dataset and Teams Up with Callyope for Alzheimer's Research
The Alzheimer's Drug Discovery Foundation's new SpeechDx dataset aims to revolutionize Alzheimer’s diagnostics through AI partnerships and innovative research.
third-news.com
September 30, 2025 at 3:05 PM
newsen.bsky.social
ADDF's New Investment to Enhance Quality Control in Alzheimer's Biomarkers Testing#United_States#New_York#Diagnostics_Accelerator#Quality_Control#Alzheimer's_Drug_Discovery_Foundation
ADDF's New Investment to Enhance Quality Control in Alzheimer's Biomarkers Testing
The Alzheimer's Drug Discovery Foundation announces a $2M investment aimed at enhancing quality control programs for Alzheimer's biomarkers, improving diagnostic consistency.
third-news.com
June 2, 2025 at 2:52 PM
newsen.bsky.social
Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology#United_States#Boston#Life_Molecular_Imaging#Alzheimer’s_Drug_Discovery_Foundation#PET_imaging
Life Molecular Imaging Receives Funding to Study Alzheimer’s Neuroinflammation with PET Technology
Life Molecular Imaging has secured $2.16 million from the Alzheimer's Drug Discovery Foundation to enhance PET imaging research for Alzheimer’s disease neuroinflammation over three years.
third-news.com
May 20, 2025 at 1:05 PM
newsen.bsky.social
Inaugural ADDF Scientific Summit Highlights Breakthroughs in Alzheimer's Research and Treatment#USA#Palm_Beach#Alzheimer's_Drug_Discovery_Foundation#Melvin_R._Goodes_Prize#Daniel_M._Skovronsky
Inaugural ADDF Scientific Summit Highlights Breakthroughs in Alzheimer's Research and Treatment
The Inaugural ADDF Scientific Summit showcased groundbreaking advancements in Alzheimer's research, featuring top scientists and key presentations on future treatments.
third-news.com
March 6, 2025 at 10:23 PM
newsen.bsky.social
Filippo Berio Drives Healthy Eating Initiatives in the U.S. Through Strategic Partnerships#United_States#Filippo_Berio#Culinary_Careers_Program#Alzheimer's_Drug_Discovery_Foundation#Lyndhurst
Filippo Berio Drives Healthy Eating Initiatives in the U.S. Through Strategic Partnerships
Filippo Berio is advancing health and wellness in the U.S. by partnering with educational programs to promote healthy eating and healthier lifestyles.
third-news.com
February 13, 2025 at 1:26 PM